Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wiland, P.
Right arrow Articles by Szechinski, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiland, P.
Right arrow Articles by Szechinski, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The British Journal of Rheumatology, Vol 36, 59-63, Copyright © 1997 by British Society for Rheumatology

ORIGINAL PAPERS

N-acetyl-beta-D-glucosaminidase urinary excretion as an early indicator of kidney dysfunction in rheumatoid arthritis patients on low-dose methotrexate treatment

P Wiland, J Swierkot and J Szechinski
Institute of Rheumatology, Medical Academy, Wroclaw, Poland.

The N-acetyl-beta-D-glucosaminidase (NAG) activities and albumin levels in the urine of 32 patients with active rheumatoid arthritis treated with low-dose pulse methotrexate (MTX) have been investigated. An increase in NAG urinary excretion was more frequent than the incidence of micro- or macroalbuminuria on entry, and during treatment with MTX. There was also a significant decrease in NAG levels observed at week 24. Parameters such as patient's age, time from onset, previous and current treatment did not allow us to predict the degree of NAG enzymuria. We conclude that MTX does not cause marked damage to renal proximal tubules; on the contrary, the observed significant decrease of urinary NAG on week 24 could be interpreted as a beneficial effect of MTX on kidney function. Early detection of high NAG enzymuria and elevated albumin levels in urine before the initiation of MTX therapy could be helpful in predicting possible MTX toxicity probably related to impaired renal clearance of MTX. Patients withdrawn from the study for non-renal-related adverse events also had an unusually large increase in urine NAG activity and urine albumin levels.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
J. Westhuyzen, Z. H. Endre, G. Reece, D. M. Reith, D. Saltissi, and T. J. Morgan
Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit
Nephrol. Dial. Transplant., March 1, 2003; 18(3): 543 - 551.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.